￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of aprocitentan’s domestic launch time and registration approval status

2026-02-01 22:25:32

Check Details
Instructions for use and dosage of tilpotide/tilsiparatide (Mufenda) for weight loss and hypoglycemia

2026-02-01 22:25:32

Check Details
Analysis of the significance of skin rash with Pitobrutinib/Pitobrutinib (Zepali) targeted drugs

2026-02-01 22:25:32

Check Details
Talazoparib actual price reference table after medical insurance reimbursement

2026-02-01 22:25:32

Check Details
Summary of the effects, efficacy and clinical application of Crizotinib (Xalkori)

2026-02-01 22:25:32

Check Details
Whether aprocitentan is included in medical insurance and its reimbursement ratio and self-payment

2026-02-01 22:25:32

Check Details
Analysis of the target and physiological mechanism of action of tilpotide/tilsiparatide (Mufenda)

2026-02-01 22:25:32

Check Details
Analysis of whether the disease will relapse rapidly after discontinuation of Pitobrutinib/Pitobrutinib (Zepali)

2026-02-01 22:25:32

Check Details
Is the dosage form of Talazoparib (Tazena) capsules or other forms?

2026-02-01 22:25:32

Check Details
Crizotinib price and reference after medical insurance reimbursement in 2026

2026-02-01 22:25:32

Check Details
Mechanism and pharmacological analysis of aprocitentan in the treatment of pulmonary arterial hypertension

2026-02-01 22:25:32

Check Details
Clinical application effect of tilpotide/tilsiparatide (Mufenda) in the treatment of diabetes

2026-02-01 22:25:32

Check Details
Category
相关知识